Altamira Therapeutics Ltd. Adjustments For Interest Income
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Interest Income of CHF 71.81 thousand for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-04-22.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForInterestIncome · last filed 2024-04-22
| Period end | Adjustments For Interest Income 12 month | Adjustments For Interest Income 12 month as first filed |
|---|---|---|
| 2023-12-31 | 71.81K CHF 20-F/A · filed 2024-04-22 | |
| 2022-12-31 | 12.19K CHF 20-F/A · filed 2024-04-22 | |
| 2021-12-31 | 8.59K CHF 20-F · filed 2023-05-16 | |
| 2020-12-31 | 7.43K CHF 20-F · filed 2022-04-12 | |
| 2019-12-31 | 22.20K CHF 20-F · filed 2021-03-31 | |
| 2018-12-31 | 36.30K CHF 20-F · filed 2020-04-16 | -1.05M CHF 20-F · filed 2019-03-14 |
| 2017-12-31 | -1.57M CHF 20-F · filed 2019-03-14 | |
| 2016-12-31 | -748.84K CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | 36.39K CHF 20-F · filed 2018-03-22 |